{
  "created_at": "Sat Nov 20 7:39:49 +0000 2021",
  "id_str": "1461902392383975424",
  "full_text": "Patients with both covid-19 and parasitic worms may have benefitted from the drug ivermectin https://t.co/JOt9aUmdK8",
  "display_text_range": [
    0,
    116
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/JOt9aUmdK8",
        "expanded_url": "https://econ.st/3kOtPUj",
        "display_url": "econ.st/3kOtPUj",
        "indices": [
          93,
          116
        ]
      }
    ]
  },
  "user": {
    "name": "The Economist",
    "screen_name": "TheEconomist",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/879361767914262528/HdRauDM-_normal.jpg"
  },
  "retweet_count": 29,
  "favorite_count": 93,
  "possibly_sensitive": false,
  "original_created_at": "Sat Nov 20 03:41:05 +0000 2021",
  "localize": [
    {
      "locale": "ja",
      "full_text": "covid-19と寄生虫の両方を患っている患者は、イベルメクチンという薬の恩恵を受けているかもしれない https://t.co/JOt9aUmdK8"
    },
    {
      "locale": "zh",
      "full_text": "同时患有covid-19和寄生虫的病人可能从药物伊维菌素中受益https://t.co/JOt9aUmdK8。"
    },
    {
      "locale": "zh-Hant",
      "full_text": "同時患有covid-19和寄生蟲的病人可能從藥物伊維菌素中受益https://t.co/JOt9aUmdK8。"
    }
  ]
}